{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:04:35Z","timestamp":1772445875245,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The National Key Research and Development Program of China","award":["No. 2022YFC2705100"],"award-info":[{"award-number":["No. 2022YFC2705100"]}]},{"name":"The National Key Research and Development Program of China","award":["No. 2022YFC2705103"],"award-info":[{"award-number":["No. 2022YFC2705103"]}]},{"name":"The National Key Research and Development Program of China","award":["2022YFC2705104"],"award-info":[{"award-number":["2022YFC2705104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00467-025-07066-9","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:14:51Z","timestamp":1764677691000},"page":"1061-1068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of efficacy of single-dose and double-dose rituximab in the treatment of refractory nephrotic syndrome in children: a retrospective study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0846-1921","authenticated-orcid":false,"given":"Junli","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoqun","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-0400","authenticated-orcid":false,"given":"Shengyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"7066_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0140-6736(18)30536-1","volume":"392","author":"DG Noone","year":"2018","unstructured":"Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392:61\u201374. https:\/\/doi.org\/10.1016\/s0140-6736(18)30536-1","journal-title":"Lancet"},{"key":"7066_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052450","volume":"11","author":"F Lugani","year":"2021","unstructured":"Lugani F, Angeletti A, Ravani P, Vivarelli M, Colucci M, Caridi G, Verrina E, Emma F, Ghiggeri GM (2021) Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol. BMJ Open 11:e052450\u2013e052450. https:\/\/doi.org\/10.1136\/bmjopen-2021-052450","journal-title":"BMJ Open"},{"key":"7066_CR3","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.352421","volume":"32","author":"O Alkandari","year":"2021","unstructured":"Alkandari O, Alshami AA, Alhammadi EA (2021) Practice of childhood nephrotic syndrome management among pediatric nephrologists in the GCC countries. Saudi J Kidney Dis Transpl 32:1600\u20131600. https:\/\/doi.org\/10.4103\/1319-2442.352421","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"7066_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.kint.2019.09.033","volume":"97","author":"EY Chan","year":"2020","unstructured":"Chan EY, Webb H, Yu E, Ghiggeri GM, Kemper MJ, Ma AL, Yamamura T, Sinha A, Bagga A, Hogan J, Dossier C, Vivarelli M, Liu ID, Kamei K, Ishikura K, Saini P, Tullus K (2020) Both the rituximab dose and maintenance immunosuppression in steroid-dependent\/frequently-relapsing nephrotic syndrome have important effects on outcomes. Kidney Int 97:393\u2013401. https:\/\/doi.org\/10.1016\/j.kint.2019.09.033","journal-title":"Kidney Int"},{"key":"7066_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3760\/cma.j.issn.0578-1310.2017.10.003","volume":"55","author":"Subspecialty Group of Renal Diseases, the Society of Pediatrics, Chinese Medical Association","year":"2017","unstructured":"Subspecialty Group of Renal Diseases, the Society of Pediatrics, Chinese Medical Association (2017) Evidence-based guideline on diagnosis and treatment of steroid-sensitive, relapsing\/steroid-dependent nephrotic syndrome in children (2016). Zhonghua Er Ke Za Zhi [Chinese Journal of Pediatrics] 55:729\u2013734. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2017.10.003","journal-title":"Zhonghua Er Ke Za Zhi [Chinese Journal of Pediatrics]"},{"key":"7066_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2215\/cjn.08570722","volume":"18","author":"EY Chan","year":"2022","unstructured":"Chan EY, Yap DY, Colucci M, Ma AL, Parekh RS, Tullus K (2022) Use of rituximab in childhood idiopathic nephrotic syndrome. Clin J Am Soc Nephrol 18:533\u2013548. https:\/\/doi.org\/10.2215\/cjn.08570722","journal-title":"Clin J Am Soc Nephrol"},{"key":"7066_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00467-015-3245-9","volume":"31","author":"H Webb","year":"2015","unstructured":"Webb H, Jaureguiberry G, Dufek S, Tullus K, Bockenhauer D (2015) Cyclophosphamide and rituximab in frequently relapsing\/steroid-dependent nephrotic syndrome. Pediatr Nephrol 31:589\u2013594. https:\/\/doi.org\/10.1007\/s00467-015-3245-9","journal-title":"Pediatr Nephrol"},{"key":"7066_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","volume":"19","author":"K Benz","year":"2004","unstructured":"Benz K, Dotsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19:794\u2013797. https:\/\/doi.org\/10.1007\/s00467-004-1434-z","journal-title":"Pediatr Nephrol"},{"key":"7066_CR9","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","volume":"34","author":"G Salles","year":"2017","unstructured":"Salles G, Barrett M, Fo\u00e0 R, Maurer J, O\u2019Brien S, Valente N, Wenger M, Maloney DG (2017) Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience. Adv Ther 34:2232\u20132273. https:\/\/doi.org\/10.1007\/s12325-017-0612-x","journal-title":"Adv Ther"},{"key":"7066_CR10","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","volume":"27","author":"MJ Kemper","year":"2012","unstructured":"Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber LT, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, D\u00f6tsch J (2012) Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant 27:1910\u20131915. https:\/\/doi.org\/10.1093\/ndt\/gfr548","journal-title":"Nephrol Dial Transplant"},{"key":"7066_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00467-018-4172-3","volume":"34","author":"AP Maxted","year":"2018","unstructured":"Maxted AP, Dalrymple RA, Chisholm D, McColl J, Tse Y, Christian MT, Reynolds BC (2018) Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome. Pediatr Nephrol 34:855\u2013863. https:\/\/doi.org\/10.1007\/s00467-018-4172-3","journal-title":"Pediatr Nephrol"},{"key":"7066_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00467-024-06619-8","volume":"40","author":"R Sinha","year":"2024","unstructured":"Sinha R, Pradhan S, Raut S, Banerjee S, Sarkar S, Akhtar S, Dasgupta D, Poddar S, Mandal M, Kamal VK, Chaudhury AR, Tse Y (2024) Single (375 mg\/m2) vs. double dose of rituximab along with mycophenolate mofetil for children with steroid-dependent\/frequently relapsing nephrotic syndrome: a multicentre open-label randomized controlled trial. Pediatr Nephrol 40:995\u20131004. https:\/\/doi.org\/10.1007\/s00467-024-06619-8","journal-title":"Pediatr Nephrol"},{"key":"7066_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1310032","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Chen J, Zhang Y, Wang X, Wang J (2024) Immunosuppressive agents for frequently relapsing\/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis. Front Immunol 15:1310032. https:\/\/doi.org\/10.3389\/fimmu.2024.1310032","journal-title":"Front Immunol"},{"key":"7066_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102671","volume":"19","author":"P Gauckler","year":"2020","unstructured":"Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, Hru\u0161kov\u00e1 Z, Jeyabalan A, Karras A, King C, Kohli HS, Maas R, Mayer G (2020) Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - what is known and what is still unknown? Autoimmun Rev 19:102671. https:\/\/doi.org\/10.1016\/j.autrev.2020.102671","journal-title":"Autoimmun Rev"},{"key":"7066_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1319744","volume":"14","author":"Y Chen","year":"2024","unstructured":"Chen Y, Shen Q, Xiong Y, Dong M, Xu H, Li Z (2024) Using real-world data to inform dosing strategies of rituximab for pediatric patients with frequent-relapsing or steroid-dependent nephrotic syndrome: a prospective pharmacokinetic-pharmacodynamic study. Front Pharmacol 14:1319744. https:\/\/doi.org\/10.3389\/fphar.2023.1319744","journal-title":"Front Pharmacol"},{"key":"7066_CR16","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/s0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384:1273\u20131281. https:\/\/doi.org\/10.1016\/s0140-6736(14)60541-9","journal-title":"Lancet"},{"key":"7066_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.1323","volume":"172","author":"B Basu","year":"2018","unstructured":"Basu B, Sander A, Roy B, Preussler S, Barua S, Mahapatra TKS, Schaefer F (2018) Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: a randomized clinical trial. JAMA Pediatr 172:757. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.1323","journal-title":"JAMA Pediatr"},{"key":"7066_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00467-018-4052-x","volume":"34","author":"J Hogan","year":"2018","unstructured":"Hogan J, Dossier C, Kwon T, Macher M-A, Maisin A, Couderc A, Niel O, Baudouin V, Desch\u00eanes G (2018) Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 34:253\u2013259. https:\/\/doi.org\/10.1007\/s00467-018-4052-x","journal-title":"Pediatr Nephrol"},{"key":"7066_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10157-023-02374-6","volume":"27","author":"R Ohyama","year":"2023","unstructured":"Ohyama R, Fujinaga S, Sakuraya K, Hirano D, Ito S (2023) Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study. Clin Exp Nephrol 27:865\u2013872. https:\/\/doi.org\/10.1007\/s10157-023-02374-6","journal-title":"Clin Exp Nephrol"},{"key":"7066_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2024.2427173","volume":"46","author":"X-L Niu","year":"2024","unstructured":"Niu X-L, Gu Y-F, Feng D, Hao S, Kuang X-Y, Wang P, Huang W-Y (2024) Long term evaluations of first single-dose Rituximab in children with steroid-dependent minimal-change nephrotic syndrome. Ren Fail 46:2427173. https:\/\/doi.org\/10.1080\/0886022x.2024.2427173","journal-title":"Ren Fail"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07066-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-07066-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07066-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:16:46Z","timestamp":1772443006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-07066-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7066"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-07066-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the Second Affiliated Hospital of South China University of Technology (approval number:\u00a0K-2025\u2013068-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Authors state no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}